RARE DISEASES A–Z · LETTER P

Primary Lateral Sclerosis

Primary lateral sclerosis (PLS) is a rare motor neuron disease affecting only the upper motor neurons — the long fibres from brain to spinal cord. It causes slowly progressive stiffness and weakness, usually starting in the legs. It is best understood by contrast with its relative, ALS: same system, very different tempo.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Primary lateral sclerosis is a slow motor neuron disease affecting only the upper motor neurons: progressive stiffness of legs, arms, speech, and swallowing without muscle wasting. It is far slower than ALS, and care focuses on spasticity, mobility, and safety.

The guide

The basics

Upper motor neurons run from the motor cortex down the lateral columns of the spinal cord (hence 'lateral sclerosis' — scarring of those columns). When they degenerate, muscles lose their commands and, just as importantly, lose the inhibitory control that keeps reflexes and tone in check. The result is stiffness that itself becomes the disability: legs that scissor and drag, arms that lose dexterity, and speech and swallowing muscles that slow and stiffen (pseudobulbar palsy), often with exaggerated emotional responses — laughing or crying that erupts out of proportion (pseudobulbar affect). Unlike ALS, there is no muscle wasting or twitching, because the lower motor neurons that directly supply muscle remain intact. Onset is usually after 40, and progression is measured in years to decades.

How it works

There is no biomarker. Diagnosis requires the full picture: progressive pure upper motor neuron signs for at least two years (four for a 'definite' label under current criteria), EMG studies showing no lower motor neuron damage, and MRI of brain and spine excluding structural mimics — cord compression, multiple sclerosis, and tumours can all imitate PLS and some are treatable. Blood tests exclude metabolic mimics such as B12 and copper deficiency. Hereditary spastic paraplegia is the closest genetic mimic and is considered, particularly with a family history or very slow course. Because some PLS later declares itself as ALS, neurologists keep the diagnosis under review in the early years.

Day to day

Treatment is symptomatic and rehabilitative. Anti-spasticity medicines (baclofen, tizanidine, and related agents) ease stiffness; botulinum toxin targets specific muscles; and an implanted baclofen pump helps severe leg spasticity. Physiotherapy — stretching, strengthening within tolerance, hydrotherapy — maintains range and walking; occupational therapy adapts the home and provides splints and aids; mobility equipment is introduced progressively so independence is preserved rather than surrendered. Speech therapy supports communication and swallowing safety, and pseudobulbar affect responds to specific medicines. Emotional and psychological support matters: a decades-long, slowly disabling condition with an uncertain early label takes its toll. Participation in motor neuron disease clinics gives access to the full team even though the prognosis differs from ALS.

When to get help

Reviews track mobility, spasticity, speech and swallowing, mood, and safety at home. Falls prevention is a standing agenda item — home assessment, aids, and hip protection where appropriate. Report choking episodes, chest infections, new muscle wasting or twitching (which would change the diagnosis), or low mood. Driving needs periodic honest review. Because PLS is rare and slowly progressive, connecting with motor neuron disease associations — whose services cover PLS — gives access to equipment loans, benefits advice, and peer experience that local services may lack. Advance planning can proceed at a measured pace, matching the disease's own tempo.

See a doctor promptly if: Choking with inability to clear the airway, a fall with head injury, or new muscle wasting or twitching (which changes the diagnosis) needs prompt assessment.

Common questions

How is PLS different from ALS?

PLS affects only the upper motor neurons (brain to spinal cord). ALS affects both upper and lower motor neurons — the lower involvement causes muscle wasting, twitching, and much faster progression. PLS progresses far more slowly and does not shorten life to the same degree; the distinction matters enormously for prognosis.

Can PLS turn into ALS?

In a minority, yes — some people diagnosed with PLS later develop lower motor neuron signs and are reclassified as ALS, which is why the diagnosis requires several years of pure upper motor neuron signs. After about four years without lower signs, conversion becomes much less likely.

Does PLS shorten life?

In typical adult-onset PLS, lifespan is close to normal — the disease disables mobility and speech over decades rather than threatening breathing in the way ALS does. Swallowing and falls are the main safety issues to manage.

How is PLS diagnosed if there is no test?

It is a clinical diagnosis supported by exclusion: examination shows pure upper motor neuron signs, EMG shows no lower motor neuron damage, and MRI excludes cord compression and other mimics. Criteria require symptoms to have been present for at least two years (probable) to four years (definite) before the label is firm.

More in Letter P

Related

Sources

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Spasticity and mobility management are individual; follow your neurology team's plan.